October 3, 2010

Lawsuits, Just the Cost of Criminal Marketing of Antipsychotic Drugs

A New York Times report (below) reviews what has been accomplished by multiple civil and criminal lawsuits

Read More
Lawsuits, Just the Cost of Criminal Marketing of Antipsychotic Drugs

September 10, 2010

FDA Expands Market for Another Toxic Antipsychotic

According to a report by the Associated Press, the FDA has approved expanded use of Merck’s toxic

Read More
FDA Expands Market for Another Toxic Antipsychotic

September 2, 2010

Child’s Ordeal Shows Risks of Antipsychotic Drugs for Young

A “must read” front page article by New York Times reporter, Duff Wilson, “Child’s Ordeal Shows Risks

Read More
Child’s Ordeal Shows Risks of Antipsychotic Drugs for Young

August 23, 2010

Making a Killing–Marketing Exercises by Dr. Carl Elliott

Kudos to Carl Elliott, MD, PhD,  whose powerful article, “Making a Killing,” published in Mother Jones, is

Read More
Making a Killing–Marketing Exercises by Dr. Carl Elliott

June 17, 2010

NIH Reform Compromised By Chief NIMH Psychiatrist

An investigative report by The Chronicle of Higher Education (June 6, 2010) provided details about the surrreptitious

Read More
NIH Reform Compromised By Chief NIMH Psychiatrist

February 22, 2010

Rebecca Riley’s Murderous Care Remembered

While it came as no surprise that Rebecca Riley’s mother was convicted of murder, most observers–including, it

Read More
Rebecca Riley’s Murderous Care Remembered

October 28, 2009

Nursing Homes: Psychotropic Drug Abuse

In the second half of the twentieth century, Soviet psychiatrists collaborated with their government: Soviet psychiatrists prescribed

Read More
Nursing Homes: Psychotropic Drug Abuse

October 27, 2009

NAMI Constituency Betrayed

Senator Charles Grassley has hit the bull’s eye when he asked the NAMI (National Alliance on Mental

Read More
NAMI Constituency Betrayed

September 3, 2009

Pfizer’s $2.3 Billion Settlement Leaves Victims in the lurch

The level of corruption that the pharmaceutical industry engages in–with assistance by prominent academic physicians who prostitute

Read More
Pfizer’s $2.3 Billion Settlement Leaves Victims in the lurch

August 16, 2009

FDA Approves Another Dangerous Antipsychotic, Asenapine

The FDA has approved Schering Plough’s new antipsychotic, asenapine (Saphris), for the treatment of schizophrenia and mania

Read More
FDA Approves Another Dangerous Antipsychotic, Asenapine

July 29, 2009

Pfizer-Neurontin Trial Testimony:”snake-oil list”

In 2004, Pfizer settled an illegal Neurontin marketing case with the U.S. Justice Department for $430 million. 

Read More
Pfizer-Neurontin Trial Testimony:”snake-oil list”

July 17, 2009

Is the Schizophrenia Mortality Study in The Lancet CREDIBLE?

A study purporting to analyze mortality rates of 66, 881 schizophrenia patients in Finland (1973 to 2005)

Read More
Is the Schizophrenia Mortality Study in The Lancet CREDIBLE?

June 7, 2009

Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?

FDA officials are ignoring the real world tragedies–drug-induced deaths of children. Unfortunately for the children, child psychiatrists

Read More
Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?

June 4, 2009

Marketing Trumps Safety: the case of Antipsychotics

Just as the FDA is convening an advisory committee hearing (June 9-10) about whether to expand the

Read More
Marketing Trumps Safety: the case of Antipsychotics